
Opinion|Videos|April 28, 2025
Clinical Benefits of BPH Treatments
Author(s)Christopher E. Kelly, MD
Panelist discusses how clinical data from multiple studies demonstrate that aqua ablation therapy offers efficacy comparable with that of transurethral resection of the prostate (TURP) while providing superior safety, functionality, and durability benefits.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Aqua Ablation Therapy Benefits
Efficacy:
- Aqua ablation demonstrates noninferior, equal, or superior results compared with TURP (gold standard).
- Measured by International Prostate Symptom Score and Qmax (flow rate).
- 5-year data confirm strong symptom improvement comparable with TURP.
Safety:
- Urinary incontinence:0.1% (aqua ablation) vs up to 7%+ (TURP)
- Blood transfusion rate:0.1% (aqua ablation), lower than TURP
- Ejaculation preservation:89%-90% (aqua ablation) vs ~75% (TURP)
- Erectile dysfunction rate:0% for aqua ablation
Durability:
- Retreatment rate (5 years):
- TURP: ~12%
- Aqua ablation: ~6% (half of TURP’s rate)
Aqua ablation provides a safer, more durable alternative to TURP with comparable or superior efficacy.
Advertisement
Related to this article

Rezūm improved symptoms and quality of life at 1 year vs combination pharmacotherapy in sexually active men with BPO while preserving sexual function.
Advertisement
Advertisement
Trending on Urology Times
1
Study compares PSMA-PET radiopharmaceuticals in prostate cancer recurrence
2
Variation in PSMA PET Adoption for Prostate Cancer Care
3
FDA grants 510(k) clearance to OpenFlo urinary catheter
4
FDA grants fast track designation to VIR-5500 for mCRPC
5
